Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
BackgroundIdentifying patients with low muscle mass is crucial for the diagnosis of sarcopenia. Although the Creatinine/Cystatin C (Cr/CysC) is recommended as a simplified indicator to identify patients with low muscle mass, its ability to assess muscle mass and predict a poor prognosis has not been...
Main Authors: | Shanshan Shi, Yizhou Jiang, Weihua Chen, Kaihong Chen, Ying Liao, Kun Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2022.897774/full |
Similar Items
-
Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
by: Chan‐Young Jung, et al.
Published: (2022-08-01) -
Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
by: Mariko Tsukagoshi, et al.
Published: (2023-09-01) -
Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01) -
Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis
by: Wen-He Zheng, et al.
Published: (2023-01-01) -
Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
by: Jung Nam An, et al.
Published: (2022-09-01)